These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2105472)

  • 1. Paternal origin of new mutations in von Recklinghausen neurofibromatosis.
    Jadayel D; Fain P; Upadhyaya M; Ponder MA; Huson SM; Carey J; Fryer A; Mathew CG; Barker DF; Ponder BA
    Nature; 1990 Feb; 343(6258):558-9. PubMed ID: 2105472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in von Recklinghausen neurofibromatosis: an hypothesis.
    Zlotogora J
    Am J Med Genet; 1993 Apr; 46(2):182-4. PubMed ID: 8484407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.
    Riccardi VM; Dobson CE; Chakraborty R; Bontke C
    Am J Med Genet; 1984 May; 18(1):169-76. PubMed ID: 6430086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parental origin of mutations in sporadic cases of Treacher Collins syndrome.
    Splendore A; Jabs EW; Félix TM; Passos-Bueno MR
    Eur J Hum Genet; 2003 Sep; 11(9):718-22. PubMed ID: 12939661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis in Gothenburg, Sweden. IV. Genetic analyses.
    Samuelsson B; Akesson HO
    Neurofibromatosis; 1989; 2(2):107-15. PubMed ID: 2516454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of von Recklinghausen neurofibromatosis in Dunedin, New Zealand.
    Fuller LC; Cox B; Gardner RJ
    Neurofibromatosis; 1989; 2(5-6):278-83. PubMed ID: 2518509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A boy with neurofibromatosis 1 and Poland anomaly.
    Alembik Y; Stoll C
    Genet Couns; 1994; 5(2):167-70. PubMed ID: 7917126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage analysis of Von Recklinghausen neurofibromatosis: chromosomes 4 and 19.
    Dietz JN; Robbins T; Cannon LA; Schwartz CE; Carey JC; Johnson JP; Kivlin J; Skolnick MH
    Genet Epidemiol; 1986; 3(5):313-21. PubMed ID: 3096816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1.
    Altarescu G; Brooks B; Kaplan Y; Eldar-Geva T; Margalioth EJ; Levy-Lahad E; Renbaum P
    Hum Reprod; 2006 Aug; 21(8):2047-51. PubMed ID: 16740526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis: novel and recurrent mutations in Turkish patients.
    Terzi YK; Oguzkan S; Anlar B; Aysun S; Ayter S
    Pediatr Neurol; 2007 Dec; 37(6):421-5. PubMed ID: 18021924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discounting an adverse maternal effect on severity of neurofibromatosis.
    Riccardi VM; Wald JS
    Pediatrics; 1987 Mar; 79(3):386-93. PubMed ID: 3103092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool.
    Elyakim S; Lerer I; Zlotogora J; Sagi M; Gelman-Kohan Z; Merin S; Abeliovich D
    Am J Med Genet; 1994 Dec; 53(4):325-34. PubMed ID: 7864041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues.
    Bunin GR; Needle M; Riccardi VM
    Genet Epidemiol; 1997; 14(5):507-16. PubMed ID: 9358268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
    Buteică E; Stoicescu I; Burada F; Stănoiu B
    Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental origin of mutations of the retinoblastoma gene.
    Dryja TP; Mukai S; Petersen R; Rapaport JM; Walton D; Yandell DW
    Nature; 1989 Jun; 339(6225):556-8. PubMed ID: 2733786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo mutations in familial adenomatous polyposis (FAP).
    Ripa R; Bisgaard ML; Bülow S; Nielsen FC
    Eur J Hum Genet; 2002 Oct; 10(10):631-7. PubMed ID: 12357334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion.
    Ainsworth PJ; Chakraborty PK; Weksberg R
    Hum Mutat; 1997; 9(5):452-7. PubMed ID: 9143926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?
    Kehrer-Sawatzki H; Cooper DN
    J Med Genet; 2008 Oct; 45(10):622-31. PubMed ID: 18511569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis.
    Aretz S; Uhlhaas S; Caspari R; Mangold E; Pagenstecher C; Propping P; Friedl W
    Eur J Hum Genet; 2004 Jan; 12(1):52-8. PubMed ID: 14523376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.